Samuel Clarke

Dr. Samuel Clarke is an expert in the development of nanoparticles for research, diagnostic and therapeutic applications with more than 15 years’ experience in the field. Samuel is the Director of Product Development at Precision NanoSystems Inc. where he is responsible for the development of lipid nanoparticle reagents for genetic medicine applications. Samuel previously worked for STEMCELL Technologies Inc. where he invented and commercialized magnetic nanoparticle technologies for research and cell therapy applications. He has PhD and post-doc in quantum dot nanoparticles from McGill University and École Normale Supérieure.